KRAKATOA INC. – Trademark Portfolio
Entity Type: 03
KRAKATOA INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include PTERIA, BULA KING, BULA SHOT, KAVA DEPOT, and SOLOMON GOLD. The owner is based in PALM BAY, FL.
2510 KIRBY CIRCLE NE, #110
PALM BAY, FL 32905
Showing of trademarks Trademarks
Trademark Classifications
KRAKATOA INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does KRAKATOA INC. have?
KRAKATOA INC. has 10 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 abandoned.
What trademark classes does KRAKATOA INC. file in?
KRAKATOA INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 43 (Hotels & Restaurants), Class 36 (Insurance & Financial). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are KRAKATOA INC.'s most well-known trademarks?
KRAKATOA INC.'s registered trademark portfolio includes well-known marks such as PTERIA, BULA KING, BULA SHOT, KAVA DEPOT, and SOLOMON GOLD. These are among 9 currently registered trademarks in the portfolio.
What is KRAKATOA INC.'s trademark registration success rate?
KRAKATOA INC. has a 90% trademark registration rate, with 9 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.